Arine Raises Series C to Scale AI-Driven Medication Optimization and Power Value-Based Outcomes

Arine筹集C轮融资，用于扩大AI驱动的药物优化并助力价值导向的结果

Town Hall Ventures Leads $30M Funding Round, with Participation from Kaiser Permanente Ventures

市政厅风险投资公司领投3000万美元融资回合，凯撒永久风险投资公司参与其中。

SAN FRANCISCO, June 24, 2025-- Today Arine, the leader in AI-driven medication intelligence, announced a Series C funding round. Town Hall Ventures, known for backing transformative healthcare solutions, led the round with participation from Kaiser Permanente Ventures and other existing investors. This $30 million dollar round brings Arine's total funding to $66 million and cements Arine's position at the forefront of healthcare innovation, empowering the company to accelerate its mission of redefining medication management across the healthcare continuum at a time when the industry faces unprecedented financial and regulatory pressures..

旧金山，2025年6月24日——今天，AI驱动的药物智能领域的领导者Arine宣布完成了C轮融资。本轮融资由以支持变革性医疗解决方案著称的Town Hall Ventures领投，Kaiser Permanente Ventures和其他现有投资者参与。这轮3000万美元的融资使Arine的总融资额达到6600万美元，进一步巩固了Arine在医疗创新前沿的地位，使其能够在行业面临前所未有的财务和监管压力之际，加速实现重新定义整个医疗连续体药物管理的使命。

'This is a defining moment for healthcare and for Arine,' said Yoona Kim, PharmD, PhD, CEO and co-founder of Arine. 'Mounting cost pressures and sweeping policy changes are forcing the industry to rethink how care is delivered. Amid these challenges, medications have emerged as one of the most powerful—and underleveraged—tools to improve outcomes and control costs.

“这是医疗保健行业和Arine的一个决定性时刻，”Arine首席执行官兼联合创始人、药学博士、哲学博士Yoona Kim表示，“不断上升的成本压力和广泛的政策变化正在迫使行业重新思考如何提供医疗服务。在这些挑战中，药物已成为改善结果和控制成本最有力且尚未充分利用的工具之一。”

With this new capital, we're expanding our ability to deliver meaningful impact for each patient, when the system needs it most.'.

有了这笔新资金，我们正在增强在系统最需要的时候为每位患者提供有意义的影响的能力。

Arine's AI platform focuses on the critical area of medication optimization, delivering scalable, personalized, and cost-effective medication therapy that is essential to success in value-based care. Designed for leading health plan and risk-bearing providers, Arine's platform leverages large, diverse datasets to identify the right individuals, recommend the most effective interventions, and continuously measure impact to ensure meaningful outcomes..

Arine的人工智能平台专注于药物优化这一关键领域，提供可扩展、个性化且具有成本效益的药物治疗方案，这对基于价值的医疗成功至关重要。该平台专为领先的健康计划和承担风险的供应商设计，利用庞大而多样化的数据集来识别合适的个体，推荐最有效的干预措施，并持续衡量影响以确保有意义的结果。

Arine's approach has consistently achieved >10% in total cost savings and >40% reduction in hospitalizations. These outcomes have led to >100% growth in the last year and an average contract expansion of 80% with existing clients.

阿琳的方法持续实现了总成本超过10%的节省和住院率超过40%的降低。这些成果使得去年增长超过了100%，与现有客户的平均合同扩展了80%。

'The rising cost of medications and the consequences of suboptimal medication use presents significant opportunities for innovation, particularly using AI. What sets Arine apart is not just its transformative technology, but its ability to consistently deliver measurable value for clients across populations, especially in underserved communities.

“药品成本不断上升，以及药物使用不当带来的后果，为创新提供了重要机会，尤其是在利用人工智能方面。Arine 的独特之处不仅在于其变革性的技术，还在于它能够持续为不同人群的客户带来可衡量的价值，特别是在服务不足的社区。

The company's phenomenal leadership team combines deep clinical and AI expertise with a bold vision for the future,' said Andy Slavitt, General Partner at Town Hall Ventures. 'Their platform is not just solving today's problems—it's anticipating tomorrow's challenges. We're proud to support Arine as they drive the next wave of healthcare innovation.'.

“这家公司非凡的领导团队将深厚的临床和人工智能专业知识与对未来的宏大愿景结合在一起，”Town Hall Ventures的普通合伙人安迪·斯拉维特表示，“他们的平台不仅解决了当前的问题，还在预见明天的挑战。我们很自豪能够支持Arine推动下一波医疗创新。”

'We've been partnering with Arine since 2020, and year after year, the value has been clear,' said Caroline Carney, MD, MSc, FAPA, FAPM, CPHQ, President and Chief Medical Officer at Magellan Health. 'Arine continues to expand the capabilities of their platform in ways that drive even greater impact—advancing evidence-based quality, improving patient-centered outcomes, and delivering meaningful cost savings.

“自2020年以来，我们一直与Arine合作，年复一年，其价值显而易见，”Magellan Health总裁兼首席医疗官Caroline Carney（医学博士、理学硕士、FAPA、FAPM、CPHQ）表示。“Arine继续以推动更大影响力的方式扩展其平台功能——提升基于证据的质量、改善以患者为中心的成果，并实现有意义的成本节约。”

It's that ongoing evolution that makes them such a valuable long-term partner.'.

正是这种持续的进化使他们成为如此有价值的长期合作伙伴。

With the new funding, Arine will focus on several key areas to meet evolving industry needs. Arine plans to expand its capabilities in specialty pharmacy management — a fast-growing and costly area of healthcare. At the same time, the company is accelerating AI innovation to automate high-volume, low-complexity tasks, allowing providers to focus more on direct patient care.

有了新的资金，Arine 将专注于几个关键领域以满足不断变化的行业需求。Arine 计划扩展其在特殊药房管理方面的能力，这是医疗保健领域中一个快速增长且成本高昂的部分。同时，该公司正在加速人工智能创新，以自动化高数量、低复杂性的任务，使医疗服务提供者能够更加专注于直接的患者护理。

Arine will also continue to integrate comprehensive data to further personalize medication therapy. Together, these advancements expand Arine's impact and set a new standard for how technology can drive scalable, meaningful change in healthcare..

Arine 还将继续整合综合数据，以进一步个性化药物治疗。这些进步共同扩大了 Arine 的影响力，并为技术如何推动医疗保健领域可扩展且有意义的变革树立了新标准。

About Arine

关于阿琳

Arine is a leading AI-powered medication optimization platform that improves patient outcomes and reduces healthcare costs by ensuring that patients receive the most effective and appropriate medications. By integrating advanced analytics with deep clinical expertise, Arine provides timely, personalized recommendations, enabling health plans and at-risk provider organizations to enhance medication safety, adherence, and effectiveness among their members.

Arine 是一个领先的AI驱动的药物优化平台，通过确保患者获得最有效和最合适的药物来改善患者治疗效果并降低医疗成本。通过将高级分析与深厚的临床专业知识相结合，Arine 提供及时、个性化的建议，帮助健康计划和承担风险的医疗机构提升其成员的用药安全性、依从性和有效性。

Learn more at arine.io..

更多内容请访问 arine.io。

About Town Hall Ventures

关于城镇大厅风险投资公司

Founded in 2018, Town Hall Ventures has invested in or participated in the build of 40 companies that improve how care is provided to underserved and under-represented communities. Select portfolio companies include Cityblock Health, Curana Health, Equality Health, Habitat Health, Landmark Health, Suvida Health, Strive Health, Thyme Care, and Unite Us.

成立于2018年的Town Hall Ventures已经投资或参与建立了40家改善服务不足和代表性不足社区护理方式的公司。其精选的投资组合公司包括Cityblock Health、Curana Health、Equality Health、Habitat Health、Landmark Health、Suvida Health、Strive Health、Thyme Care和Unite Us。

Learn more at www.townhallventures.com..

请访问www.townhallventures.com了解更多信息。